advertisement
Abstract #105753 Published in IGR 23-3
Glaucoma progression. Clinical practice guide
Jaumandreu L; Antón A; Pazos M; Rodriguez-Uña I; Rodriguez Agirretxe I; Martinez De La Casa JM; Ayala ME; Parrilla-Vallejo M; Dyrda A; Díez-Álvarez L; Rebolleda G; Muñoz-Negrete FJArchivos de la Sociedad Espanola de Oftalmologia 2023; 98: 40-57
OBJECTIVE: To provide general recommendations that serve as a guide for the evaluation and management of glaucomatous progression in daily clinical practice based on the existing quality of clinical evidence. METHODS: After defining the objectives and scope of the guide, the working group was formed and structured clinical questions were formulated following the PICO (Patient, Intervention, Comparison, Outcomes) format. Once all the existing clinical evidence had been independently evaluated with the AMSTAR 2 (Assessment of Multiple Systematic Reviews) and Cochrane "Risk of bias" tools by at least two reviewers, recommendations were formulated following the Scottish Intercollegiate Guideline network (SIGN) methodology. RESULTS: Recommendations with their corresponding levels of evidence that may be useful in the interpretation and decision-making related to the different methods for the detection of glaucomatous progression are presented. CONCLUSIONS: Despite the fact that for many of the questions the level of scientific evidence available is not very high, this clinical practice guideline offers an updated review of the different existing aspects related to the evaluation and management of glaucomatous progression.
Servicio de Oftalmología, Hospital Universitario Ramón y Cajal, IRYCIS, Universidad de Alcalá, Alcalá de Henares, Madrid, Spain; Red de Oftalmología RETICS OFTARED del Instituto de Salud Carlos III (ISCIII), Madrid, Spain. Electronic address: Laiajaumandreu@msn.com.
Full article